Jardiance (empagliflozin)
-
Boehringer Ingelheim launches Jardiance to treat heart failure
The company receives approval from CDSCO Boehringer Ingelheim has launched an additional heart failure indication for Jardiance (empagliflozin) in India.…
Read More »